Company Filing History:
1 out of 74 
1 out of 122 
1 out of 17 
Years Active: 2018
Title: The Innovations of Sven Meuth
Introduction
Sven Meuth is a notable inventor based in Muenster, Germany. He has made significant contributions to the field of neurology through his innovative patents. With a total of 2 patents, his work focuses on diagnosing and treating neurological disorders.
Latest Patents
One of Sven Meuth's latest patents is titled "Detection of anti-neurochondrin autoantibody in patients with cerebellar ataxia or cerebellitis." This patent provides polypeptides that include Neurochondrin and autoantibodies binding to these polypeptides. The methods described in this patent aim to diagnose or treat diseases associated with neurological symptoms or cancers. Specifically, the diagnosis may involve detecting an autoantibody binding to Neurochondrin in a patient sample, while treatment may include administering a polypeptide comprising Neurochondrin.
Another significant patent is "Factor XII inhibitors for the treatment of neurological inflammatory disorders." This application addresses neurological inflammatory diseases, such as multiple sclerosis. It outlines methods for administering a Factor XII inhibitor to prevent, treat, or ameliorate the effects of such diseases. Additionally, it provides agents and pharmaceutical compositions that inhibit the activity of Factor XII.
Career Highlights
Sven Meuth has worked with prominent companies in the pharmaceutical industry, including CSL Behring GmbH and CSL Limited. His experience in these organizations has contributed to his expertise in developing innovative solutions for neurological disorders.
Collaborations
Sven has collaborated with notable colleagues, including Kerstin Goebel and Christoph Kleinschnitz. These partnerships have further enhanced his research and development efforts in the field of neurology.
Conclusion
Sven Meuth's contributions to the field of neurology through his patents demonstrate his commitment to advancing medical science. His innovative approaches to diagnosing and treating neurological disorders have the potential to significantly impact patient care.